This EUA was pushed to have something positive to report at the RNC. The result is the bar is set ankle high for therapeutics and the medical community is still left wanting something that can do a better job.
Brilacidin will be welcomed with open arms as it will
not require donors and doesn’t come with any of the risks associated with blood products and the challenges of storing and shipping blood products.
(10)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.